How to Distribute Pharmaceutical and Health Products in Vietnam: The Full Channel Map (2026)

Most brands think the wholesale distributor is the gate in Vietnamese pharma. It is not. On paper the system looks simple: manufacturer to national distributor to provincial distributor to pharmacy. In practice it is layered, and the real gatekeepers are the hospital procurement committees and the pharmacy chain buyers. International brands that understand this get listed faster and stay listed longer.

The market is worth the effort. Vietnam’s pharmaceutical and health product market grew 12% in 2025, reaching USD 8.1 billion in total market value. An aging population (7.7% of Vietnamese are over 65, a figure rising fast), rising per-capita income and a lasting trust in imported pharmaceutical brands over domestic generics make Vietnam one of Southeast Asia’s most attractive health markets for international brands. But the distribution infrastructure is specific, regulated, and runs on relationships.

The five distribution layers in Vietnam’s pharmaceutical sector

Layer 1: National pharmaceutical distributors (Dược Hà Tây, Vimedimex, Zuellig Pharma Vietnam, Mega Lifesciences). These importers hold the import licenses and keep the main relationship with Vietnam’s Ministry of Health and the Drug Administration of Vietnam (DAV). For most international pharmaceutical and health product brands, one of them is the first partner.

Layer 2: Provincial and regional distributors. Each of Vietnam’s 63 provinces has its own pharmaceutical distribution infrastructure. National distributors supply provincial distributors, who supply the pharmacy and clinical channel in their province. For tier-2 and tier-3 city coverage beyond HCMC and Hanoi, the provincial relationship is a must, and international brands that focus only on national-level agreements often miss it.

Layer 3: Hospital procurement. Government hospitals in Vietnam buy through a formal tender system (bidding committees) that weighs price, clinical documentation and registered product status. To enter the hospital channel, an international pharmaceutical brand needs local registration, clinical evidence documentation in Vietnamese, and usually a national distributor with active hospital tender experience. This channel is slow to build. Once a brand is in, it gives the highest volume per SKU.

Layer 4: Pharmacy chains. Long Chau (1,800+ locations), Pharmacity (1,100+ locations), An Khang (900+ locations) and Medicare. These chains are the fastest-growing pharmaceutical retail channel in Vietnam, and they are expanding hard into tier-2 cities. International OTC health products and supplement brands enter Vietnam mainly through pharmacy chains, not hospital procurement. The chain buyers are demanding: they want DAV registration, competitive pricing and co-marketing investment. In our view this is the real gate for most foreign health brands.

Layer 5: Traditional pharmacy (nha thuoc). Vietnam’s traditional independent pharmacy network is estimated at 60,000+ outlets nationwide. They still dominate in rural and semi-urban areas. Provincial distributors and local wholesalers serve them. For national reach, traditional pharmacy coverage needs a distributor with provincial wholesaler relationships, not just modern chain connections.

The regulatory prerequisite: DAV registration

Every pharmaceutical and health supplement product sold in Vietnam needs either a full DAV drug registration (for pharmaceutical drugs) or a MOH health food notification (for supplements and OTC health products). That choice decides your whole distribution channel strategy. Pharmaceutical drug registration makes you eligible for hospital procurement but takes 12 to 36 months and costs USD 10,000 to 50,000 per product. Health supplement notification is faster (4 to 8 weeks) and cheaper (USD 500 to 2,000 per SKU), but it shuts you out of hospital procurement. Pick your regulatory pathway from your channel strategy, not just your product classification. (Most brands do it the other way round.)

Four national distributors

Zuellig Pharma Vietnam: the most international-minded of Vietnam’s national pharmaceutical distributors. It has the widest hospital channel relationships and the most documented experience with imported brand representation. Its terms are professional, but its minimum volumes are high for brands arriving with a short product range.

Mega Lifesciences: specializes in OTC health products and supplements alongside prescription pharmaceuticals. Strong pharmacy chain relationships. Relevant for international brands sitting between pharmaceutical drug and supplement.

Vimedimex: a large Vietnamese-owned national distributor with strong government hospital and provincial distributor relationships. Relevant for brands that want Vietnam’s public hospital channel more than the pharmacy chains.

DKSH Vietnam: the distribution arm of Swiss market expansion group DKSH, with strong modern trade and pharmacy relationships across Southeast Asia. If you already work with DKSH in other Asian markets, extending to Vietnam through them is often the fastest route (not always the cheapest one, though).

Case study: Swiss pharmaceutical brand enters Long Chau in 9 months

A Swiss OTC pharmaceutical brand (digestive health category, strong EU registration) came to Asia Pro in early 2025. It wanted Vietnam’s pharmacy channel without full pharmaceutical drug registration, which would have taken 18 to 24 months. The product qualified for health supplement notification (MOH) instead of full DAV registration, and that shortened the regulatory timeline a lot.

We connected them with Mega Lifesciences Vietnam, which had existing Long Chau and Pharmacity buyer relationships and experience with European OTC health products. MOH notification submitted in week 4. Mega Lifesciences Long Chau buyer introduction at week 6. First Long Chau listing confirmed at month 8. Year-one Vietnam pharmacy channel revenue: USD 165,000. Long Chau reorder volume at month 12 confirmed year-two expansion to the An Khang network.

The lesson: the regulatory pathway (pharmaceutical drug versus supplement notification) decides your time to market more than any other single choice in Vietnam’s health product distribution. Spend USD 500 on a regulatory classification consultation before assuming you need full pharmaceutical registration.

Case study: Australian vitamin brand gets listed then loses the listing

An Australian vitamin brand entered Vietnam through a HCMC-based pharmaceutical distributor in 2022. The distributor got it into 120 independent pharmacies (nha thuoc) in HCMC through its wholesale network. Initial sell-through was acceptable. But the brand gave no co-marketing support, no KOL health content and no in-store display materials. After 8 months the independent pharmacies stopped reordering. Pharmacist recommendation drives 60% of purchases in traditional Vietnamese pharmacies, and the pharmacists were not backing the brand. No endorsement, no consumer pull. The product sat on the shelf.

The brand switched distributors 14 months into its Vietnam operation. The new distributor had pharmacy chain relationships and also ran pharmacist education sessions: 30-minute product briefings for pharmacy staff at new locations. Sell-through in chain locations with pharmacist briefings was 3 times the rate of locations without them. The pharmacist channel is not passive in Vietnam. It is the main recommendation engine for OTC health products.

The lesson: in Vietnam’s traditional pharmacy channel, the pharmacist’s recommendation drives purchases more than consumer advertising. Any OTC health product strategy in Vietnam needs a pharmacist education component next to consumer-facing KOL content. Honestly, a 30-minute briefing is the cheapest marketing in this whole article.

Doctors on TikTok

Vietnamese health content on TikTok and YouTube is heavily shaped by medical doctors and pharmacists who have built their own creator followings. These “medical KOLs” (bac si/duoc si content creators) carry much more purchase credibility than celebrity health endorsements. A product reviewed positively by a Vietnamese medical doctor with 200,000 YouTube followers generates pharmacy sell-through that advertising cannot copy. International pharmaceutical and health brands that bring Vietnamese medical content creators into their market entry consistently beat brands that rely on standard beauty/wellness KOL content.

On Facebook, Vietnamese health community groups (focused on specific conditions: diabetes, hypertension, immunity, bone health) are where patients and caregivers share product experiences. A product mentioned positively there by a credible member generates word-of-mouth that flows into pharmacy recommendations. Brands with effective products that engage these communities honestly (through clinical content, not promotional posts) build credibility that pays off in pharmacy sell-through.

Notice the pattern? Pharmacist in the shop, doctor on TikTok. In Vietnam, the white coat sells.

FAQ: Pharmaceutical distribution in Vietnam

Do I need DAV drug registration to sell OTC health products in Vietnam?

Not necessarily. Products positioned as health supplements (functional food) use MOH health food notification instead of DAV drug registration. The key distinction is whether your product makes specific therapeutic claims (requires DAV registration) or general health claims (eligible for MOH notification). Many OTC products that need pharmaceutical registration in Europe can be reclassified as health supplements in Vietnam if their claims are adjusted. A Vietnamese regulatory consultant can assess your product in 2 to 3 business days and recommend the fastest compliant pathway.

How do I get a product listed on the Long Chau or Pharmacity buyer’s radar?

Long Chau and Pharmacity buyers receive hundreds of new product proposals monthly. The ones that get meetings share: completed MOH/DAV registration, documented sell-through data from at least one Asian market (South Korea and Australia are the most credible references for Vietnamese pharmacy buyers), a Vietnamese-language product information sheet with clinical backing, and a co-marketing investment budget for the first quarter. Cold approaches without these rarely get meetings. A warm introduction through a qualified distributor that already supplies the chain converts to a meeting at 5 to 10 times the rate of direct brand outreach.

What margin do Vietnamese pharmaceutical distributors require?

National pharmaceutical distributors (Zuellig, Mega, Vimedimex, DKSH) typically require 20 to 35% margin on CIF Vietnam cost. Pharmacy chains require 25 to 40% gross margin on their purchase price from the distributor. Together, this means international health product brands need to price at 2.5 to 3.5 times their Vietnam CIF cost to reach a viable end-consumer price. It sounds wide, but it matches premium health product pricing in Vietnamese pharmacy channels, where consumers already expect premium international brand pricing.

How long does full pharmaceutical drug registration in Vietnam take in 2026?

DAV pharmaceutical drug registration: 18 to 36 months from application to approval, depending on product category and how complete the documentation is. Vietnam has recently set up an expedited review pathway for products with EU, US FDA or Australian TGA registration: expedited review targets 12 to 18 months. It requires submitting the complete dossier from the reference country’s regulatory approval at the same time as the Vietnam application. Brands that want hospital procurement in Vietnam have no alternative to full DAV registration. The timeline is fixed. Plan your market entry around it.

What stays uncertain is the expedited pathway. It targets 12 to 18 months, but targets are not results. Has any brand you know actually seen a Vietnamese registration land inside that window?


Entering Vietnam’s Health and Pharmaceutical Market?

Asia Pro Distribution connects international health and pharmaceutical brands with qualified Vietnamese distributors, regulatory consultants, and pharmacy chain buyers.

Vietnam health distribution | Distribution services | Contact our team

more on distribution in Vietnam

See also how we find distributors in Vietnam.

A meeting in Vietnam

A distributor in Hanoi told us why he likes small new brands: “Big names already have a partner. A new brand needs me, so we build it together.” He buys at 25 to sell at 100, a 1:4 ROI, and wants exclusivity in return. He added that there are only a few serious players in his category, so brands should not waste his time. We know because we sit in these meetings in Vietnam. Read also: the 5 common mistakes with Vietnamese distributors.

RELATED ARTICLES

Leave the first comment